Showing posts with label brachytherapy research journals. Show all posts
Showing posts with label brachytherapy research journals. Show all posts

Monday, 19 June 2017

Childhood Cancer Care in Developing Countries; Challenge

Childhood Cancer Care
Dealing with children who have cancer in developing countries is a great human experience not only for the patient and the family but also for persons who are caring them.

The diagnosis of a child as a cancer case is really a great shock to all family members and it is a moment of a dramatic change in their life. First reaction is usually a combination of sadness and denial.

They will start a new style of life with a plenty of investigations, appointments and different treatments decisions and plans. Different negative emotional reactions are the classic feelings of the parents every time they meet the treating physician.

Thursday, 1 June 2017

Childhood Cancer Care in Developing Countries; Challenge

Childhood Cancer Care
Dealing with children who have cancer in developing countries is a great human experience not only for the patient and the family but also for persons who are caring them.

The diagnosis of a child as a cancer case is really a great shock to all family members and it is a moment of a dramatic change in their life. First reaction is usually a combination of sadness and denial.


They will start a new style of life with a plenty of investigations, appointments and different treatments decisions and plans. Different negative emotional reactions are the classic feelings of the parents every time they meet the treating physician.

Thursday, 12 January 2017

Development of Thulium-170 Brachytherapy Sources and Application in Rats Treatment

Experimental work where Tm-170 LDR seeds and one HDR source were used to treat cancer on rats is described. Experiments were done with Lewis rats, carrying tumor developed from implantation of CNS-1 Rat Brain Tumor Astrocytoma cells, under the thigh skin. 75% of both HDR and LDR treated rats were completely cured.

Rats Treatment
I-125 seeds experiments were done as a control, only 8.3% were cured with a similar photon dose. The dose due to beta radiation is very significant and was the main reason for the treatment success.

Tm-170 seeds and a source were developed and tested for brachytherapy. The two common brachytherapy methods were used in the present work; permanent implantation, or low dose rate, LDR, where low activity seeds are implanted and remain inside the tumor, and temporary implantation of a high dose rate (HDR) source, where a high activity source stays inside the tumor for a short time and then removed